Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (44)

2024

  1. Biocompatibility Testing of UV-Curable Polydimethylsiloxane for Human Umbilical Vein Endothelial Cell Culture on-a-Chip

    ACS Omega, Vol. 9, Núm. 28, pp. 30281-30293

  2. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2022

  1. Impact of Enhanced Phagocytosis of Glycated Erythrocytes on Human Endothelial Cell Functions

    Cells, Vol. 11, Núm. 14

  2. Minimal invasive fluorescence methods to quantify advanced glycation end products (AGEs) in skin and plasma of humans

    Methods, Vol. 203, pp. 103-107

  3. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  4. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (Journal of Molecular Medicine, (2021), 99, 7, (943-953), 10.1007/s00109-021-02054-6)

    Journal of Molecular Medicine

  2. Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

    Journal of Molecular Medicine, Vol. 99, Núm. 7, pp. 943-953

  3. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis

    Scientific Reports, Vol. 11, Núm. 1

  4. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  5. Microfluidic devices manufacturing with a stereolithographic printer for biological applications

    Materials Science and Engineering C, Vol. 129

  6. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

2020

  1. Antirhea borbonica aqueous extract protects albumin and erythrocytes from glycoxidative damages

    Antioxidants, Vol. 9, Núm. 5

  2. COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity

    Revista Espanola de Cardiologia

  3. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients

    Shock, Vol. 53, Núm. 4, pp. 400-406

2019

  1. Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production

    Free Radical Research, Vol. 53, Núm. 2, pp. 150-169

  2. Inflammatory effects of in vivo glycated albumin from cardiovascular patients

    Biomedicine and Pharmacotherapy, Vol. 113

2018

  1. Determination of hemodynamic risk for vascular disease in planar artery bifurcations

    Scientific Reports, Vol. 8, Núm. 1

  2. Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide

    Journal of Biological Chemistry, Vol. 293, Núm. 13, pp. 4778-4791

  3. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 2, pp. 280-291